Catalog No.:AA00H08I

892489-52-0 | trans-4-[4-[[[5-[(3,4-Difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbonyl]amino]phenyl]cyclohexaneacetic acid

Name: Name:trans-4-[4-[[[5-[(3,4-Difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbonyl]amino]phenyl]cyclohexaneacetic acid
Brand: AABLOCKS
SKU: AA00H08I
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

10mg

≥98%(HPLC)

in stock

$481.00 $337.00

- +

50mg

≥98%(HPLC)

in stock

$1,418.00 $993.00

- +

Technical Information
Properties
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Literature

Technical Information

Catalog Number:

AA00H08I

Chemical Name:

trans-4-[4-[[[5-[(3,4-Difluorophenyl)amino]-1,3,4-oxadiazol-2-yl]carbonyl]amino]phenyl]cyclohexaneacetic acid

CAS Number:

892489-52-0

Molecular Formula:

C23H22F2N4O4

Molecular Weight:

456.4420

MDL Number:

MFCD13184802

SMILES:

OC(=O)C[C@@H]1CC[C@H](CC1)c1ccc(cc1)NC(=O)c1nnc(o1)Nc1ccc(c(c1)F)F

Properties

Computed Properties

Complexity:

671

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

4.7

Literature

Title: Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.

Journal: ACS medicinal chemistry letters 20140508

Title: Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes.

Journal: Bioorganic & medicinal chemistry letters 20120615

Title: McCoull W, et al. Identification, optimisation and in vivo evaluation of oxadiazole DGAT-1 inhibitors for the treatment of obesity and diabetes. Bioorg Med Chem Lett. 2012 Jun 15;22(12):3873-8.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS